Expression of γ-glutamylcysteine synthetase (γ-GCS) and Multidrug Resistance-associated Protein (MRP), but not human canalicular Multispecific Organic Anion Transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1089-1096

  Oguri, T ^a   Fujiwara, Y ^a   Isobe, T ^a   Katoh, O ^b   Watanabe, H ^b   Yamakido, M ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Canalicular multispecific organic anion transporter; Drug resistance; Multidrug resistance associated protein; GCS heavy subunit; GCS light subunit

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMATE CYSTEINE LIGASE; MULTIDRUG RESISTANCE PROTEIN; PLATINUM DERIVATIVE;

ADULT; AGED; ANION TRANSPORT; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANION TRANSPORT PROTEINS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CISPLATIN; DNA TOPOISOMERASES, TYPE I; FEMALE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RNA, MESSENGER;

EID: 0031881908     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.181     Document Type: Article

References (38)

1. Bailey HH, Gipp JJ, Ripple M, Wilding G and Mulcahy RT (1992) Increase in γ-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res 52:5115-5118
2. Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271: 15091-15098
3. Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, Irino S and Saijo N (1990) Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum (II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res 50: 2549-2553
4. Chuman Y, Chen Z-S, Sumizawa T, Furukawa T, Haraguchi M, Takebayashi Y, Niwa K, Yamada K, Aikou T and Akiyama S (1996) Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. Biochem Biophys Res Commun 226: 158-165
5. De Vries EGE, Müller M, Meijer C, Jansen PLM and Mulder NH (1995) Role of the glutathione S-conjugate pump in cisplatin resistance. J Natl Cancer Inst 87: 537-538
6. Fujii R, Mutoh M, Sumizawa T, Chen Z-S, Yoshimura A and Akiyama S (1994) Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J Natl Cancer Inst 86: 1781-1784
7. Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew KD and Saijo N (1990) Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res 81: 527-535
8. Gipp JJ, Chang C and Mulcahy RT (1992) Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase. Biochem Biophys Res Commun 185: 29-35
9. Gipp JJ, Bailey HH and Mulcahy RT (1995) Cloning and sequencing of the cDNA for the light subunit of human liver γ-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues. Biochem Biophys Res Commun 206: 584-589
10. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070-3074
11. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K and Kondo T (1995) Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res 55: 4297-4301
12. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361
13. Huang C-S, Chang L-S, Anderson ME and Meister A (1993) Catalytic and regulatory properties of the heavy subunit of rat kidney γ-glutamylcysteine synthetase. J Biol Chem 268: 19675-19680
14. Ishikawa T and Ali-Osman F (1993) Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-depcndent efflux from leukemia cells. J Biol Chem 268: 20116-20125
15. Ishikawa T, Wright CD and Ishizuka H (1994) GS-X pump is functionally overexpresscd in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 269: 29085-29093.
16. Ishikawa T, Bao J-J, Yamane Y, Akimaru K, Frindrich K, Wright CD and Kuo MT (1996) Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem 271: 14981-14988
17. Jedlitschky G, Leier I, Buchholz U, Center M and Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836
18. Kleiner DE, Emmert-Buck MR and Liotta LA (1995) Necropsy as a research method in the age of molecular pathology. Lancet 346: 945-948.
19. Kondo T, Yoshida K, Urata Y, Goto S, Gasa S and Taniguchi N (1993) γ-glutamylcysteine synthetase and active transport of glutathione 5-conjugate are responsive to heat shock in K562 erythroid cells. J Biol Chem 268: 20366-20372
20. Kuo MT, Bao J-J, Curley SA, Ikeguchi M, Johnston DA and Ishikawa T (1996) Frequent coordinated overexpression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res 56: 3642-3644
21. Kurokawa H, Ishida T, Nishio K, Arioka H, Sata M, Fukumoto H, Miura M and Saijo N (1995) γ-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione 5-conjugate export pump and cisplatin resistance. Biochem Biophys Res Commun 216: 258-264
22. Leier I, Jedlitschky G, Buchholz U, Cole SPC, Deeley RG and Keppler D (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269: 27807-27810
23. Mitsuhashi M, Cooper A, Ogura M, Shinagawa T, Yano K and Hosokawa T (1994) Oligonucleotide probe design - a new approach. Nature 367: 759-761
24. Mulcahy RT and Gipp JJ (1995) Identification of a putative antioxidant response element in the S'-flanking region of the human γ-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 209: 227-233
25. Mulcahy RT, Bailey HH and Gipp JJ (1994) Up-regulation of γ-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother Pharmacol 34: 67-71
26. Mulcahy RT, Bailey HH and Gipp JJ (1995) Transfection of complementary DNAs for the heavy and light subunits of human γ-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res 55: 4771-4775
27. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, De Vries EGE and Jansen PLM (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione 5-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
28. Nooter K, Bosman FT, Burger H, Van Wingerden KE, Flens MJ, Scheper RJ, Oostrum RG, Boersma AWM, Van Der Gaast A and Stoter G (1996) Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol 7: 75-81
29. O'Brien ML and Tew KD (1996) Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A: 967-978
30. O'Dwyer PJ, Szarka CE, Yao K-S, Halbherr TC, Pfeiffer GR, Green F, Gallo JM, Brennan J, Frucht H, Goosenberg EB, Hamilton TC, Litwin S, Balshem AM, Engstrom PF and Clapper ML (1996) Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J Clin Invest 98: 1210-1217
31. Ohashi N, Fujiwara Y, Yamaoka N, Katoh O, Satow Y and Yamakido M (1996) No alteration in DNA topoisomerase 1 gene related to CPT-11 resistance in human lung cancer. Jpn J Cancer Res 87: 1280-1287
32. Paulusma CC, Bosma PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, Borst P and Oude Elferink RPJ (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128
33. Stewart DJ, Grewaal D, Redmond MD, Mikhael NZ, Montpetit VAJ, Goel R and Green RM (1993) Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide. Cancer Chemother Pharmacol 32: 368-372
34. Taniguchi K., Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, and Kuwano M (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124-4129
35. Tothill P, Klys HS, Matheson LM, McKay K and Smyth JF (1992) The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Eur J Cancer 28: 1358-1361
36. Yao K-S, Godwin AK, Ozols RF, Hamilton TC and O'Dwyer PJ (1993) Variable baseline γ-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment. Cancer Res 53: 3662-3666
37. Yao K-S, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ and Hamilton TC (1995) Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res 55: 4367-4374
38. Zhu Q and Center MS (1994) Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 54: 4488-4492